Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients (Q44146619)

30 November 2017

Valacyclovir versus acyclovir for HSV prophylaxisin neutropenic patients (English)

1 reference

30 November 2017

0 references

1 reference

8

Fawziah Marra

1 reference

30 November 2017

Dawn I Warkentin

1

1 reference

30 November 2017

Joel B Epstein

2

1 reference

30 November 2017

Lara M Campbell

3

1 reference

30 November 2017

Judy G Yip

4

1 reference

30 November 2017

Victoria C Cox

5

1 reference

30 November 2017

Allison Ransier

6

1 reference

30 November 2017

Michael J Barnett

7

1 reference

30 November 2017

language of work or name

English

0 references

publication date

1 October 2002

1 reference

Annals of Pharmacotherapy

30 November 2017

1 reference

30 November 2017

36

1 reference

30 November 2017

10

1 reference

30 November 2017

1525-1531

1 reference

Varicella zoster virus infections following allogeneic bone marrow transplantation: frequency, risk factors, and clinical outcome.

30 November 2017

1 reference

Human herpesvirus-6 meningoencephalitis in a recipient of an unrelated allogeneic bone marrow transplantation.

21 January 2018

1 reference

Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir

21 January 2018

1 reference

Acyclovir prophylaxis of herpes-simplex-virus infections

21 January 2018

1 reference

Infections in bone marrow transplant recipients

21 January 2018

1 reference

Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation

21 January 2018

1 reference

Acyclovir given as prophylaxis against oral ulcers in acute myeloid leukaemia: randomised, double blind, placebo controlled trial

21 January 2018

1 reference

Oral Acyclovir for Prevention of Herpes Simplex Virus Reactivation After Marrow Transplantation

21 January 2018

1 reference

Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy

21 January 2018

1 reference

Pharmacokinetics of the acyclovir pro-drug valaciclovir after escalating single- and multiple-dose administration to normal volunteers

21 January 2018

1 reference

Absolute bioavailability and metabolic disposition of valaciclovir, the L-valyl ester of acyclovir, following oral administration to humans

21 January 2018

1 reference

Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study. International Valaciclovir HSV Study Group

21 January 2018

1 reference

Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group

21 January 2018

1 reference

A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections. The Valaciclovir International Study Group.

21 January 2018

1 reference

21 January 2018

1 reference

Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A434

1 reference

30 November 2017

1 reference